News – Page 532 – Endpoints News

Updated: Gilead collects 5th priority review voucher as public advocacy group urged the company to relinquish it

4 years ago

After Roundup debacle, Bayer's shareholders vote against management pay scheme

4 years ago

Biotech’s biggest investor is prepping a whopping $4.75B wager on the future of the industry

4 years ago

Exclusive: Bipartisan letter to Merrick Garland warns of opioid overdose drug shortages

4 years ago

Pharma marketers, take note: Rural patients have technology, but lag in trust and health confidence, study says

4 years ago

The R&D challenge: 4 top drug hunters talk best practices in building a biotech today

4 years ago

FDA guidance machine churns out 8 new documents in less than a week

4 years ago

FDA hits Hutchmed, Junshi drugs with CRLs — further clarifying its stance on China-only data

4 years ago

RA-backed PepGen sets terms for upcoming IPO; Sanofi commences dosing of Denali candidate in ALS

4 years ago

Wilson's disease treatment from Orphalan gets the go-ahead after PhIII

4 years ago

Axsome's migraine drug issued CRL a week after the biotech outlined CMC concerns

4 years ago

Another public biotech hops on the trial-win-to-stock-sale train, netting a nine-figure raise

4 years ago

Facing backlash for potential Sabatini appointment, NYU administrators defend hiring process — report

4 years ago

Stealth's lead drug flunks again, this time in an eye disease, but biotech will attempt to push forward

4 years ago

FDA puts a hold on Vertex’s attempted diabetes cure

4 years ago

Klick Health hires big-name creative talent, adds new style title and working group

4 years ago

After culling workforce, migraine biotech Zosano drops lead — and sole — program

4 years ago

A former Gary Glick biotech, now a penny stock, will lay off staff and close offices after PhII fail

4 years ago

Just weeks after he stepped down as chairman, Emergent's former CEO dies at age 64

4 years ago

Gilead joins a lineup of Big Pharma partners betting big on TriNKETs, with a $300M cash ante to get started on a 5T4

4 years ago

James Boylan snags $300M to hunt for biotech deals after leaving SVB

4 years ago

After spearheading historic Covid effort, Pfizer vaccine R&D chief Kathrin Jansen to retire

4 years ago

For once, Pfizer's Covid pill fails in a trial — but only after seeking a much broader population

4 years ago

Fake news? Narcan maker forced to refute licensing deal after wire service apparently duped by false announcement

4 years ago

First page Previous page 529 530 531532533 534 535 Next page Last page